SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008821
Filing Date
2018-11-07
Accepted
2018-11-07 16:43:28
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20180930x10q.htm 10-Q 2442175
2 EX-10.1 vygr-20180930ex10166512a.htm EX-10.1 108997
3 EX-10.3 vygr-20180930ex1037c3c17.htm EX-10.3 98342
4 EX-31.1 vygr-20180930ex3111fae14.htm EX-31.1 20047
5 EX-31.2 vygr-20180930ex312abf73c.htm EX-31.2 20044
6 EX-32.1 vygr-20180930ex321415616.htm EX-32.1 15396
7 GRAPHIC vygr20180930x10q001.jpg GRAPHIC 88010
  Complete submission text file 0001558370-18-008821.txt   8436225

Data Files

Seq Description Document Type Size
8 EX-101.INS vygr-20180930.xml EX-101.INS 1779057
9 EX-101.SCH vygr-20180930.xsd EX-101.SCH 52875
10 EX-101.CAL vygr-20180930_cal.xml EX-101.CAL 51497
11 EX-101.DEF vygr-20180930_def.xml EX-101.DEF 200642
12 EX-101.LAB vygr-20180930_lab.xml EX-101.LAB 426956
13 EX-101.PRE vygr-20180930_pre.xml EX-101.PRE 335958
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 181166945
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1